Zentalis Pharmaceuticals, Inc. (ZNTL)

NASDAQ: ZNTL · IEX Real-Time Price · USD

3.700

-0.250 (-6.33%)

At close: Jul 19, 2024, 4:00 PM

3.840

+0.140 (3.78%)

Pre-market: Jul 22, 2024, 8:07 AM EDT

Zentalis Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	263	1,072	1,149	3,808	2,109
Market Cap Growth	9.43%	-6.72%	-69.82%	80.54%	-
Enterprise Value	-186	630	755	3,510	1,771
PE Ratio	-	-3.67	-4.85	-23.99	-17.90
PS Ratio	6.48	-	-	-	-
PB Ratio	0.57	2.45	2.65	10.46	6.84
P/FCF Ratio	-5.30	-5.14	-6.91	-23.77	-24.09
P/OCF Ratio	-5.31	-5.16	-7.02	-24.71	-24.30
EV/Sales Ratio	16.50	-	-	-	-
EV/EBITDA Ratio	-3.07	-2.16	-3.20	-22.15	-15.10
EV/EBIT Ratio	-3.05	-2.15	-3.18	-22.07	-15.08
EV/FCF Ratio	-3.17	-3.02	-4.54	-21.91	-20.22
Debt / Equity Ratio	0.09	0.10	0.10	0.12	0.00
Debt / EBITDA Ratio	-0.20	-0.15	-0.19	-0.28	-0.01
Debt / FCF Ratio	-0.20	-0.21	-0.27	-0.28	-0.01
Quick Ratio	8.97	7.00	7.77	7.80	11.90
Current Ratio	9.19	7.16	7.98	7.98	12.07
Asset Turnover	0.07	0	0	0	0
Return on Equity (ROE)	-46.10%	-63.90%	-57.40%	-50.80%	-61.50%
Return on Assets (ROA)	-37.80%	-52.00%	-46.40%	-42.30%	-42.70%
Return on Capital (ROIC)	-51.72%	-62.34%	-47.45%	-53.02%	-38.36%
Earnings Yield	-83.33%	-27.25%	-20.60%	-4.17%	-5.59%
FCF Yield	-80.36%	-19.44%	-14.47%	-4.21%	-4.15%
Buyback Yield / Dilution	-20.10%	-23.75%	-23.82%	-51.84%	-402.29%
Total Shareholder Return	-20.10%	-23.75%	-23.82%	-51.84%	-402.29%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).